Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors.
Nishiyama-Fujita Y, Nakazato T, Iriyama N, Tokuhira M, Ishikawa M, Sato E, Takaku T, Sugimoto K, Fujita H, Fujioka I, Tsuchiya S, Kimura Y, Iwanaga E, Komatsu N, Asou N, Kizaki M, Hatta Y, Kawaguchi T.
Nishiyama-Fujita Y, et al.
Ann Med. 2022 Dec;54(1):1244-1254. doi: 10.1080/07853890.2022.2069280.
Ann Med. 2022.
PMID: 35486442
Free PMC article.